Search clinical trials for: Empagliflozin high
Total 7161 results
-
Boehringer IngelheimCompleted
-
Ain Shams UniversityNot yet recruiting
-
Alexandria UniversityRecruitingHeart Failure With Reduced Ejection FractionEgypt
-
Maria Sklodowska-Curie National Research Institute...Medical Research Agency, PolandRecruiting
-
National Institute of Cardiology, Warsaw, PolandAmsterdam UMC, location VUmc; University of Eastern Finland; Medical University...RecruitingHeart Failure | Hypertrophic CardiomyopathyPoland
-
NHS Greater Glasgow and ClydeUniversity of GlasgowActive, not recruitingMyocardial InfarctionUnited Kingdom
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Aristotle University Of ThessalonikiUnknownHypertension | Type II DiabetesGreece
-
Amsterdam UMC, location VUmcRecruitingIdiopathic Pulmonary Arterial HypertensionNetherlands
-
University of Texas Southwestern Medical CenterBoehringer IngelheimCompletedDiabetes Mellitus | Heart Failure, Diastolic | Heart Failure With Preserved Ejection FractionUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina
-
Isfahan University of Medical SciencesCompletedDiabetes MellitusIran, Islamic Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Vanderbilt University Medical CenterRecruitingObesity | Metabolic SyndromeUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Boehringer...Recruiting
-
Washington University School of MedicineRecruitingEpilepsyUnited States
-
Boehringer IngelheimWithdrawnCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
China National Center for Cardiovascular DiseasesRecruitingHypertension | Pre-Heart FailureChina
-
Yale UniversityBoehringer IngelheimRecruitingLiver Failure | CirrhosisUnited States
-
University Medical Center GroningenCompletedHeart Failure; With Decompensation | Heart Failure，Congestive | Heart Failure AcuteNetherlands
-
Christian SchulzeBoehringer Ingelheim; Zentrum für Klinische Studien JenaCompletedAcute Decompensated Heart FailureGermany
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolTerminatedDiabetic NephropathiesSingapore
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedHeart Failure | Diabetes MellitusUnited Kingdom
-
Daewoong Pharmaceutical Co. LTD.Active, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic DiseaseChina
-
Hannover Medical SchoolBoehringer IngelheimNot yet recruitingAutosomal Dominant Polycystic Kidney
-
Chulalongkorn UniversityNot yet recruitingEmpagliflozin in Cardiorenal Syndrome Type 1Thailand
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Chinese University of Hong KongRecruitingAcute Heart FailureHong Kong
-
Chulalongkorn UniversityRecruitingEmpagliflozin in Post AKI Stage 2-3Thailand
-
Boehringer IngelheimRecruitingHeart FailureKorea, Republic of
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
Assiut UniversityCompleted
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
Morten SchouCompletedHeart Failure With Reduced Ejection FractionDenmark
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
AstraZenecaRecruitingChronic Kidney DiseaseSpain, Italy, China, Vietnam, United States, Brazil, Canada, Malaysia, Poland, Taiwan, Austria, Bulgaria, Chile, United Kingdom, Japan
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimRecruitingPostprandial HypoglycemiaSwitzerland
-
University of Sao Paulo General HospitalRecruitingCoronary Artery Disease | Diabetes Mellitus, Type 2 | Acute Kidney Injury | Coronary Artery Bypass SurgeryBrazil
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
Dong Wha Pharmaceutical Co. Ltd.Completed
-
Samuel Lunenfeld Research Institute, Mount Sinai...McGill University Health Centre/Research Institute of the McGill University...Completed
-
Medical University of ViennaAttoquant DiagnosticsCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3Austria
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
University Hospital TuebingenCompletedBody Weight | PreDiabetesGermany
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States
-
AstraZenecaCompletedHealthy Subjects in Fasted and Fed StateBrazil